BEUDAMED
    60 results · 25ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.
    Filters Regulation: Us FDA ×

    PVS 1300 NEURO GUIDE WIRE

    FDA 510(k)
    FDA Class 2 ·Cardiovascular

    SYNCHRO GUIDEWIRE

    FDA Adverse Event
    Malfunction ·NEUROVASCULAR DIVISION, BOSTON SCIENTIFIC CORPORATION·Product code DQX·July 9, 2009

    SYNCHRO GUIDEWIRE

    FDA Adverse Event
    Malfunction ·NEUROVASCULAR DIVISION, BOSTON SCIENTIFIC CORPORATION·Product code DQX·July 9, 2009

    SYNCHRO GUIDEWIRE

    FDA Adverse Event
    Malfunction ·NEUROVASCULAR DIVISION, BOSTON SCIENTIFIC CORP.·Product code DQX·September 4, 2009

    SYNCHRO GUIDEWIRE

    FDA Adverse Event
    Malfunction ·NEUROVASCULAR DIVISION, BOSTON SCIENTIFIC CORP.·Product code DQX·September 4, 2009

    SYNCHRO 14 NEURO GUIDEWIRE

    FDA Adverse Event
    Injury ·NEUROVASCULAR, A DIVISION OF BOSTON SCIENTIFIC CORPORATION·Product code DQX·July 24, 2007

    SYNCHRO GUIDEWIRE

    FDA Adverse Event
    Malfunction ·NEUROVASCULAR DIVISION, BOSTON SCIENTIFIC CORPORATION·Product code DQX·August 18, 2009

    SYNCHRO -10 NEURO GUIDEWIRE

    FDA Adverse Event
    Malfunction ·BOSTON SCIENTIFIC CORP., NEUROVASCULAR DIV·Product code DQX·December 15, 2006

    SYNCHRO-14 NEURO GUIDEWIRE

    FDA Adverse Event
    Malfunction ·NEUROVASCULAR , A DIV. OF BOSTON SCIENTIFIC CORP·Product code DQX·December 19, 2006

    SYNCHRO 14 GUIDEWIRE

    FDA Adverse Event
    Injury ·BOSTON SCIENTIFIC CORP.·Product code DQX·September 20, 2007

    SYNCHRO .014 GUIDEWIRE

    FDA Adverse Event
    Injury ·BOSTON SCIENTIFIC CORP. / NEUROCASCULAR DIVISION·Product code DQX·August 16, 2007

    SYNCHRO .014 GUIDEWIRE

    FDA Adverse Event
    Injury ·BOSTON SCIENTIFIC CORP. / NEUROVASCULAR DIV.·Product code DQX·August 16, 2007

    SYNCHRO -14 NEURO GUIDEWIRE

    FDA Adverse Event
    Malfunction ·BOSTON SCIENTIFIC CORP., NEUROVASCULAR DIVISION·Product code DQX·November 30, 2006

    SYNCHRO-14 NEURO GUIDEWIRE

    FDA Adverse Event
    Malfunction ·BOSTON SCIENTIFIC CORPORATION, NEUROVASCULAR DIVISION·Product code DQX·September 12, 2007

    SYNCHRO GUIDEWIRE

    FDA Adverse Event
    Malfunction ·BOSTON SCIENTIFIC CORP.·Product code DQX·October 16, 2009

    SYNCHRO 14 "S" NEURO GUIDEWIRE

    FDA Adverse Event
    Injury ·BOSTON SCIENTIFIC CORP.·Product code DQX·September 20, 2007

    SYNCHRO 10 NEURO GUIDEWIRE

    FDA Adverse Event
    Injury ·NEUROVASCULAR, A DIVISION OF BOSTON SCIENTIFIC CORP.·Product code DQX·November 7, 2007

    SYNCHRO GUIDEWIRE

    FDA Adverse Event
    Malfunction ·BOSTON SCIENTIFIC - SALT LAKE CITY·Product code DQX·April 8, 2010

    SYNCHRO-14 NEURO GUIDEWIRE

    FDA Adverse Event
    Malfunction ·NEUROVASCULAR, A DIVISION OF BOSTON SCIENTIFIC CORP·Product code DQX·July 28, 2006

    SYNCHRO-14 NEURO GUIDEWIRE

    FDA Adverse Event
    Malfunction ·NEUROVASCULAR, A DIV OF BOSTON SCIENTIFIC CORP·Product code DQX·September 14, 2006